TG Therapeutics, Inc. (LON:0VGI)
37.50
-1.05 (-2.72%)
At close: Mar 14, 2025
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
849.60K GBP
Profits / Employee
86.08K GBP
Market Cap
3.83B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Indivior | 1,051 |
TG Therapeutics News
- 8 days ago - Lightning Round: Buy anything uranium, says Jim Cramer - CNBC
- 8 days ago - Cramer's Lightning Round: TG Therapeutics is a buy - CNBC
- 11 days ago - TG Therapeutics: Strong Execution Tempered By An Evolving Market - Seeking Alpha
- 13 days ago - TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel - Seeking Alpha
- 22 days ago - Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Benzinga
- 4 weeks ago - TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - TG Therapeutics: Estimates Could Soon Be Raised Again - Seeking Alpha
- 6 weeks ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - GlobeNewsWire